Topic: Andreas Barner

Boehringer Ingelheim grows faster than the pharmaceutical market for the tenth time in succession/continued high level of investment in R&D/market launch of five innovative medicines planned

Drugs.com - 656 days ago
Ingelheim, Boehringer Ingelheim continued to grow in 2009, increasing its net sales by 9.7% to EUR 12.7 billion (2008: Boehringer Ingelheim again invested considerably in its future in 2009, the 125th year in the company's history. "These new medicines ...